NeilM.KogutMD

PubMed

• 31 citations
  Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.
  Jasmine Zain, Joycelynne Palmer, Maria Delioukina, Sandra H. Thomas, Ni-Chun Tsai
  Leukemia & Lymphoma. 2011-07-14
• 23 citations
  Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
  George Somlo, J F Simpson, Paul Frankel, Warren Chow, Lucille Leong
  British Journal of Cancer. 2002-07-29
• 61 citations
  Autologous stem cell transplantation for HIV-associated lymphoma
  Amrita Krishnan, Arturo Molina, John A. Zaia, Auayporn Nademanee, Neil Kogut
  Blood. 2001-12-15

Abstracts/Posters

• Reduced-Intensity Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia
  Stein, A., O'Donnell, M., Snyder, D., Parker, P., Nademanee, A., Falk, P., Kogut, N., Rosenthal, J., Palmer, J., Tsai, N., Forman, S., Biology of Blood and Marrow Transplantation, 2/1/2007
• Feasibility and Toxicity of Maintenance Thalidomide Following Single Cycles Autologous PBSC Transplant in Patients with Multiple Myeloma
  Sahebi, F., Somlo, G., Kogut, N., Blood, 11/1/2003
• A Fludarabine/Melphalan (Flu/Mel) Reduced Intensity Conditioning Regimen with Cyclosporine and Mycophenolate Mofetil 9CSA/MMF) Allows Successful Transplantation of Pat...
  Rodriguez, R., Parker, P., Nademanee, A., Smith, D. Stein, A., Snyder, D.S., O'Donnell, M.R., Molina, A., Bhatia, R., Fung, H.C., Krishnan, A.Y., Popplewell, L., Cohen..., BMT Program, Blood, Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope, Duarte,, 11/16/2002
• Reduced Intensity Allogeneic Stem Cell Transplantation for Patients Who Have Failed a Prior Autologous Stem Cell Transplant
  Cohen, S., Fung, H., Stein, A., Nademanee, A., Rodriguez, R., O'Donnell, M., Parker, P., Molina, A., Margolin, K., Somlo, G., Sahebi, F., Spielberger, R., Snyder, D., ..., BMT Program, Blood, Hematology/Bone Marrow Transplantation, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Pe, 11/16/2002
• Long Term Follow-Up Report on Allogeneic Stem Cell Transplantation (alloSCT) for patients with Acute Myelogneous Leukemia (AML) in First Relapse (Rel) or 2nd Complete ...
  Fung, H.C., Cohen, S., Dagis, A., O'Donnell, M., Falk, P., Kogut, N., Krishnan, A., Molina, A., Nademanee, A., Parker, P., Popplewell, L., Rodriguez, R., Slovak, M., S..., BMT Program, Blood, Div of Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope, , 11/16/2002
• Autologous Peripheral Stem Cell Transplantation (ABSCT) for Adult Patient with Hodgkin's Disease (HD); Impact of Mobilization Kinetics on Transplant Outcome
  Fung, H.C., Wang, S., Nademanee, A., Cohen, S., O'Donnell, M., Falk, P., Kogut, N., Krishnan, A., Molina, A., Parker, P., Popplewell, L., Rodriguez, R., Sahebi, F., Sm..., BMT Program, Blood, Div of Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope, , 11/16/2002
• Allogeneic Peripheral-Blood Cells Transplantation for Patients with Acute Leukemia in First Remission
  Fung HC, Snyder DS, Smith D, Gilfillan K, Molina A, O'Donnell M, Nademanee A, Parker P, Stein A, Falk P, Kogut N, Spielberger R, Cohen S, Sweetman R, Popplewell L, Rod..., Blood, 1/1/2001
• Allogeneic Stem Cell Transplantation (SCT) for Patients with Primary Refractory Acute Myelogenous Leukemia (AML): Impact of Cytogenetic Risk Group on the Transplant Ou...
  Fung HC, O'Donnell M, Popplewell L, Stein A, Nademanee A, Parker P, Slovak ML, Molina A, Smith D, Gilfillan K, Snyder DS, Krishnan A, Rodriguez R, Somlo G, Kogut N, Fa..., Blood, 1/1/2001
• Intensified Cytoreduction with High Dose Melphalan (HDM) And Stem Cell Rescue (STR) Followed by a 2nd High Dose Therapy (HDT) And Autologous Stem Cell Transplant (ASCT...
  Fung HC, Nademanee A, Stiff P, Molina A, Falk P, Kogut N, O'Donnell MR, Forman E, Ivers B, Rosenthal J, Vora N, Dagis A, Goldfarb P, Schriber J, Forman SJ, Blood, 1/1/2000
• Amifostine (AMI) Before FTBI, Followed by VP-16 Cytoxan (CY) and Autologous PBSCT for Patients with Relapsed NHL, HD and Acute Leukemia: Toxicity Analysis
  Rodriguez R, Nademanee A, Ivers B, Shear J, Bonner L, Frankel P, Molina A, Fung H, Snyder DS, O'Donnell, Spielberger R, Stein AS, Parker PM, Kashyap, Krishnan AY, Popp..., Blood, 1/1/1999
• Extracorporeal Photopheresis (EP) is Effective Treatment for Chronic Refractory Graft-Versus-Host Disease (GvHD)
  Sniecinski I, Parker P, Dagis A, Collier T, Wang S, Rickard K, Snyder D, Nademanee A, Spielberger R, Rodriguez R, Krishnan A, Fung H, Stein A, O'Donnell M, Rosenthal J..., Blood, 1/1/1998
• The Detection of KSHV Is Increased by Mobilization Chemotherapy and Reduced in Autografts by CD34-seclection
  R Vescio, C Wu, M Rettig, A Stewart, O Ballester, S Noga, H Rugo, C freytes, N Kogut, S Tarantolo, P Stiff, L Pinero, W Dalton, A Ho, G Schiller, M Benyunes, C Jacobs,..., Blood, 11/18/1997
• A Phase III Study Evaluation CD34+Selected versus Unselected Autologous Peripheral Blood Progenitor Cell Transplantation for Patients with Advanced Multiple Myeloma: E...
  G Shiller, AK Stewart, O Ballester, S Noga, H Rugo, C Freytes, E Stadtmauer, N Kogut, S Tarantolo, P Stiff, L. Pineiro, W Dalton, A Ho, R Vescio, M Benyunes, C Jacobs,..., Blood, 11/18/1997
• Myeloma Cell Tumor Reduction in PCPC Autographs following CD34 Selection: The Results of a Phase III Trial Using the CEPARATE(R) Device
  R Vescio, A Stewart, O Ballester, S Noga, H Rugo, C Freytes, E Stadtmauer, N Kogut, S Tarantolo, P Stiff, L. Pinero, W Dalton, A Ho, G Schiller, M Benyunes, C Jacobs, ..., Blood, 11/18/1997
• Increase in Circulating Tumor Cell Burden during Mobilization Chemotherapy Predicts for Relapse after Autologous Transplantation in Multiple Myeloma Patients
  A Stewart, O Ballester, S Noga, H Rugo, C Reytes, E Stadtmauer, N Kogut, S Tarantolo, P Stiff, L Pinero, W Dalton, A Ho, G Schiller, M Benyunes, C Jacobs, J DiPersio, ..., Blood, 11/18/1997
• Autologous Stem Cell Transplantation (ASCT) in 100 Patients with Hodgkin's Disease (HD) in First Relapse (1st Rel): Impact of the Conditioning Regimen (Fractionated To...
  Fung, H.C., Nademanee, A., Molina, A., Ruel, C., Ivers, B., Smith, D., Krishnan, A., Popplewell, L., Vora, N., Snyder, D., O'Donnell, M., Parker, P., Stein, A., Somlo,..., Blood, Autologous Stem Cell Transplantation (ASCT) in 100 Patients with Hodgkin's Disease (HD) in First Rel
• Use of Oral Ganciclovir (PO-GCV) For the Preemptive Treatment (TX) Of CMV following Allogeneic HCT: Safety and Feasibility Results
  Spielberger R, Szia J, Nelson RA, Newman E, Gallez-Hawkins G, Ahlers A, Stevenson J, Acedo C, Alam A, Bhatia R, Cohen S, Falk P, Fung HC, Kashyap A, Kogut N, Krishnan ..., Blood
• Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM)
  Firoozeh Sahebi, Neil M. Kogut, Ricardo Spielberger, peter M. Falk, Auayporn P. Nademanee, Leslie Popplewell, David G. Maloney, Roberto Rodriguez, Amrita Krishnan, Ryo..., Blood, Div of Hem/BMT, City of Hope Cancer Center, Duarte, CA, USA, 2002; Kaiser Permanente, City of Hope,
• Join now to see all

Lectures

• Update on Stem Cell Transplantation, Grand Rounds 
  VA Wadsworth - 9/1/2000